The Triglyceride–Glucose Index Might Be a Better Indicator for Predicting Poor Cardiovascular Outcomes in Chronic Coronary Syndrome

This study aimed to explore the potential association between triglyceride–glucose index (TyG) and atherogenic of plasma (AIP)—both considered surrogate markers for atherosclerosis—and major adverse cardiovascular events (MACEs) in patients diagnosed with chronic coronary syndrome (CCS). We conducted a retrospective analysis, encompassing 715 consecutive intermediate CCS risk, who presented at outpatient clinic June 2020 August 2022. MACEs included non-fatal myocardial infarction, hospitalization heart failure, cerebrovascular events, non-cardiac mortality, cardiac mortality. The primary outcome was composite occurrence during follow-up period. For time-to-event analysis outcome, we employed Kaplan–Meier plots Cox proportional hazard models. median age overall population 55 years, duration 17 months. Multivariate regression identified age, hypertension, Coronary Artery Disease–Reporting Data System score, TyG as independent predictors outcome. Notably, individuals high levels exhibited significantly higher rate compared those low (18.7% vs. 3.8%, p < 0.001). Similarly, elevated values demonstrated statistically rates hospitalizations infarctions, These findings suggest that may serve predictive marker outcomes CCS.